Stay updated with breaking news from Tim Demuth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tim Demuth, M.D., Ph.D., has more than 20 years of broad leadership experience in drug development, with a focus in oncology MorphoSys AG (FSE: MOR; NASDAQ: MOR) announced today that Malte Peters
DGAP-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys appoints Tim Demuth as new Chief Research and Development Officer, fol...
Pieris Pharmaceuticals, Inc (NASDAQ:NASDAQ:PIRS) Q1 2022 Earnings Conference Call May 11, 2022, 8:00 AM ET Company Participants Stephen S.
BOSTON, MA / ACCESSWIRE / January 14, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology